Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 2/20 | 0.56 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.56 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.56 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.52 |
| ▸ | HSP90AB1 | P08238 | 1/20 | 0.51 |
| ▸ | CNR1 | P21554 | 1/20 | 0.50 |
| ▸ | CNR2 | P34972 | 1/20 | 0.50 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.49 |
| ▸ | NPC1 | O15118 | 2/20 | 0.49 |
| ▸ | RAB9A | P51151 | 2/20 | 0.49 |
| ▸ | MEN1 | O00255 | 1/20 | 0.49 |
| ▸ | PARP10 | Q53GL7 | 1/20 | 0.49 |
| ▸ | ACP3 | P15309 | 1/20 | 0.48 |
| ▸ | SLC1A3 | P43003 | 1/20 | 0.47 |
| ▸ | SLC1A2 | P43004 | 1/20 | 0.47 |
| ▸ | SLC1A1 | P43005 | 1/20 | 0.47 |
| ▸ | HPGD | P15428 | 1/20 | 0.47 |
| ▸ | ATM | Q13315 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31012122 | 1.00 | CYP1A2 (0.56) | CYP1A2CYP2C19CYP2C9CYP2D6HSP90AB1 | |
| Hydroxyamine SCHEMBL8924246 | 0.94 | MEN1 (0.53) | CYP1A2CYP2C19CYP2C9CYP2D6HSP90AB1 | |
| SCHEMBL9707213 | 0.90 | TSHR (0.58) | CYP1A2CYP2C19CYP2C9CYP2D6HSP90AB1 | |
| Sulfuric Acid SCHEMBL28586052 | 0.88 | TDP1 (0.50) | CYP1A2CYP2C19CYP2C9CYP2D6HSP90AB1 | |
| SCHEMBL327701 | 0.87 | CYP1A2 (0.50) | CYP1A2CYP2C19CYP2C9CYP2D6CNR1 | |
| SCHEMBL10815296 | 0.87 | CYP1A2 (0.48) | CYP1A2CYP2C19CYP2C9CYP2D6HSP90AB1 | |
| SCHEMBL2108040 | 0.87 | CYP1A2 (0.48) | CYP1A2CYP2C19CYP2C9CYP2D6HSP90AB1 | |
| SCHEMBL10884842 | 0.84 | TDP1 (0.46) | CYP1A2CYP2C19CYP2C9CYP2D6CNR1 | |
| SCHEMBL4614172 | 0.84 | HTR1B (0.53) | CYP1A2CYP2C19CYP2C9CYP2D6CNR1 | |
| SCHEMBL29641182 | 0.84 | HTR1B (0.53) | CYP1A2CYP2C19CYP2C9CYP2D6CNR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 102 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12435049-B2 | Synthesis of vinylic protected alcohol intermediates | AMGEN INC. (US) | 2025-10-07 | — | — | US | claimed |
| CN-119585901-A | Pre-lithiated electrode material, method for producing same, secondary battery, and power utilization device | 宁德时代新能源科技股份有限公司 | 2025-03-07 | — | — | CN | claimed |
| CN-110981873-B | Preparation method for synthesizing pyrroloquinoline quinone by five-step method | 江西农业大学 | 2025-01-24 | — | — | CN | claimed |
| CN-117090046-A | Composition for reducing malodor and use thereof | 阿吉莱克斯香料和香水公司 | 2023-11-21 | — | — | CN | claimed |
| CN-115197114-A | Aromatic selenium cyanogen ester compound and green synthesis method and application thereof | 南宁师范大学 | 2022-10-18 | — | — | CN | claimed |
| CN-111170941-A | Preparation method of 1-cyclopropyl-6, 7-difluoro-8-methoxy fluoroquinolone-3-carboxylic ester | 江西农业大学 | 2020-05-19 | — | — | CN | claimed |
| CN-106831360-B | Process method for continuously preparing β -naphthyl methyl ether | 南京师范大学 | 2020-05-05 | — | — | CN | claimed |
| CN-110551153-A | Preparation method for synthesizing tenofovir alafenamide by three-step method | UNIV JIANGXI AGRICULTURAL | 2019-12-10 | — | — | CN | claimed |
| EP-3083558-B1 | PROCESS FOR THE PRODUCTION OF PHTHALIMIDES | LANXESS DEUTSCHLAND GMBH (DE) | 2017-11-15 | — | — | EP | claimed |
| US-7378410-B2 | Substituted lactams and their use as anti-cancer agents | NOVARTIS AG (CH) | 2008-05-27 | — | — | US | claimed |
| US-20060281731-A1 | Substituted lactams and their use as anti-cancer agents | BAIR, KENNETH WALTER | 2006-12-14 | — | — | US | claimed |
| EP-1651633-A1 | SUBSTITUTED LACTAMS AND THEIR USE AS ANTI-CANCER AGENTS | Novartis AG (CH) | 2006-05-03 | — | — | EP | claimed |
| WO-2005014574-A1 | SUBSTITUTED LACTAMS AND THEIR USE AS ANTI-CANCER AGENTS | NOVARTIS AG (CH) | 2005-02-17 | — | — | WO | claimed |
| EP-0557419-B1 | GRANULAR DETERGENT OR BLEACHING COMPOSITIONS CONTAINING AMIDOPEROXYACID BLEACH AND PERFUME | PROCTER & GAMBLE (US) | 1996-01-17 | — | — | EP | claimed |
| CN-117980454-B | Aldehyde composition | 三菱瓦斯化学株式会社 | 2026-05-19 | — | — | CN | disclosed |
| CN-119384487-A | Aldehyde composition | 三菱瓦斯化学株式会社 | 2025-01-28 | — | — | CN | disclosed |
| CN-110981873-B | Preparation method for synthesizing pyrroloquinoline quinone by five-step method | 江西农业大学 | 2025-01-24 | — | — | CN | disclosed |
| EP-0492940-A1 | Process for producing and purifying 3,4-dihydrocoumarin | SUMITOMO CHEMICAL COMPANY LIMITED (JP) | 1992-07-01 | — | — | EP | disclosed |
| EP-0474075-A2 | Aromatic condensation products | BAYER AG (DE) | 1992-03-11 | — | — | EP | disclosed |
| EP-0025496-A1 | Maytansinoids, their production and therapeutic compositions containing them | Takeda Chemical Industries, Ltd. (JP) | 1981-03-25 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060281731-A1 | Substituted lactams and their use as anti-cancer agents | TOP1, TOP2A, TOP2B | CYP1A2 2183/4885CYP2C19 769/4885CYP2C9 1111/4885 |
| US-12435049-B2 | Synthesis of vinylic protected alcohol intermediates | MCL1, BCL2A1, BAK1 | CYP1A2 1998/4885CYP2C19 4485/4885CYP2C9 4218/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.